Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Determine which S&P 500 index fund to buy for retirement 2024 using clear criteria, comparing options to choose confidently.
25,095 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Investors are moving past SpaceX hype toward proven AI cash generators. This report explains why NVIDIA stands out as...
Policy moves hailed by industry leaders collide with technical realities. This article explains why trump's quantum p...
Three candidates backed by mayor zohran mamdani ‘better won key NYC primaries, expanding the left-leaning bloc and si...
Nokia’s latest move isn't about handsets—it's about AI-friendly data-center networks. The Nokia acquired Infinera qui...
Cardano rolled out a major scaling testnet this week, aiming to boost throughput amid mixed market signals. ADA trade...
A landmark housing bill cleared Congress this week, promising to ease rents and expand homebuilding. President Trump ...
XRP faces renewed selling pressure as it tests critical support around $1.00, with bears signaling caution across bot...
A CFO's $2.1 million sale of OUSTER shares raises questions for investors. This analysis explains what such insider m...
Small landlords juggle rents, maintenance, and tenants. This guide shows you how to pick the best property management...
JPMorgan Chase moves to a two-person succession test by naming Doug Petno and Troy Rohrbaugh co-presidents, laying th...
Memory prices and AI data demands have put Micron and Sandisk in the spotlight. This piece breaks down what’s driving...